Collaborative Care Intervention Has Modest but Positive Results in Obesity and Depression
An integrated collaborative care intervention resulted in modest improvements in weight loss and depressive symptoms in adults with obesity and depression.
Depression
Low Field Magnetic Stimulation Shows Promise for Treatment-Resistant Depression
Low field magnetic stimulation for treatment-resistant depression may have a potentially rapid onset of action with few adverse effects.
Zulresso Approved as First Treatment for Postpartum Depression
The Food and Drug Administration (FDA) has approved Zulresso (brexanolone; Sage Therapeutics) injection for the treatment of postpartum depression in adult women, the first drug to be approved for this indication. Zulresso, an analogue of the endogenous human hormone allopregnanolone, is intended for continuous intravenous (IV) infusion over 2.5 days following a titration schedule. It…
Patient-Centered Medical Management for Depression
Researchers found that there has been little attention paid to intervention to enhance treatment adherence in nonpsychotic major depression, so they outlined steps for engagement, retention, and adherence for these patients.
Anxiety, Depression More Likely for Adults With Atopic Dermatitis
Atopic dermatitis (AD) is associated with increased depression and anxiety.
Affective Lability and Mood Reactivity Associated With Mixed, Atypical Depression
Mood reactivity and affective lability may bridge the gap between mixed and atypical depression.
Cannabis Use in Adolescence Associated With Depression, Suicidal Behavior
Preventive strategies to reduce cannabis use among youth are needed, as adolescent cannabis consumption is associated with increased risk for depression and suicidal behavior later in life.
Cognitive Behavioral Therapy Effective in Treating Depression in Patients With Parkinson Disease
Cognitive behavioral therapy may improve a diverse array of depressive symptoms in patients with Parkinson disease.
Reduced Fetal Growth Increases Risk for Mental Health, Neurodevelopmental Disorders
Reduced fetal growth was associated with a small but significant increase in the general risk for psychiatric and neurodevelopmental disorders.
Adjunctive Use of Aripiprazole Shows High Efficacy in Escitalopram Nonresponders
Aripiprazole appears to be an effective adjunctive therapy in patients with major depressive disorder who do not respond to escitalopram alone.
Next post in Depressive Disorder
